Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance | HRSA 22 025

Opportunity Information: Apply for HRSA 22 025

The Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Training and Technical Assistance funding opportunity is a federal cooperative agreement from the Health Resources and Services Administration (HRSA) within the U.S. Department of Health and Human Services. It is designed to strengthen the day-to-day capacity of state and territory ADAP programs by providing targeted training, practical tools, and hands-on technical assistance that help ADAPs operate effectively and improve health outcomes for people with HIV. The overall intent is to help ADAPs stay responsive and high-performing in a health care environment that continues to shift in areas like insurance coverage, medication access, program administration, and policy requirements. The work is explicitly tied to the national goals laid out in the HIV National Strategic Plan: A Roadmap to End the HIV Epidemic (2021-2025), meaning the assistance is meant to support broader efforts to reduce HIV transmission, improve care outcomes, and reduce disparities.

The funded organization is expected to work closely with HRSA and serve as a central source of expertise for RWHAP Part B recipients, primarily state and territory health departments that administer ADAP. A major focus is helping recipients strengthen administrative structures and operational systems so that ADAPs can run smoothly, remain compliant, and consistently serve eligible clients. Just as important, the recipient must help ADAPs build and refine their ability to implement and manage two core forms of support: medication assistance (providing access to FDA-approved HIV medications for eligible low-income individuals with limited or no coverage) and health insurance assistance (using ADAP funds, where allowed, to purchase health insurance for eligible clients and support services that improve access, adherence, and monitoring of HIV drug therapy). In practice, that means technical assistance can touch everything from eligibility processes and recertification workflows to benefits coordination, pharmacy and formulary management, and approaches that reduce barriers to staying on treatment.

A key requirement of this opportunity is that the funded entity continuously assesses what technical assistance needs exist across the Part B recipients and then adjusts its support as those needs change over time. Rather than offering one-time training, the program is framed as ongoing capacity-building: gathering feedback, identifying emerging challenges (for example, changes in coverage landscapes or operational pressures), and tailoring the assistance accordingly. Applicants are expected to clearly demonstrate deep experience and subject-matter expertise specifically relevant to ADAP operations and the realities of state and territory program administration, since the audience includes jurisdictions with different systems, policies, and resource levels. The announcement also encourages collaboration through subcontracts or memoranda of understanding, which signals that applicants can strengthen their approach by bringing in specialized partners (for example, experts in health insurance navigation, pharmacy benefit management, data systems, or quality improvement).

The opportunity clarifies what ADAP is and who it serves: ADAP is authorized under Part B of the Ryan White HIV/AIDS Program and is administered by states and territories to provide HIV medications to low-income individuals with HIV who have limited or no coverage through private insurance, Medicaid, or Medicare. It also reiterates that eligibility is determined by the state or territory and typically includes confirming HIV status along with financial and residency eligibility. ADAPs must recertify client eligibility at least every six months, which highlights why strong administrative processes matter; programs need reliable systems to document eligibility, maintain continuity of coverage, and prevent interruptions in medication access. The geographic scope is broad and includes all 50 states plus the District of Columbia and multiple U.S. territories and affiliated jurisdictions, including Puerto Rico, Guam, the U.S. Virgin Islands, American Samoa, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.

From a grants management standpoint, this is a discretionary HRSA opportunity (CFDA 93.145) using a cooperative agreement mechanism, which typically means substantial federal involvement in shaping or guiding the work compared to a standard grant. The funding opportunity number is HRSA-22-025. HRSA anticipated making a single award (Expected Awards: 1). The notice was created on August 23, 2021, with an original closing date of November 22, 2021. The eligible applicant category is listed as "Others" with additional eligibility details referenced in the full announcement, suggesting applicants may include organizations beyond state agencies, such as nonprofits, academic institutions, or other entities capable of delivering national-level training and technical assistance. The listed award ceiling is shown as 0 in the source data, which often indicates that the ceiling was not specified in that particular data extract and would need to be confirmed in the full funding announcement or HRSA guidance.

In plain terms, this opportunity funds a national technical assistance provider to help state and territory ADAP programs run stronger systems and deliver more effective medication and insurance support, so that people with HIV can start and stay on treatment and achieve better health outcomes. The successful applicant needs to show credibility in ADAP-specific operations, an ability to deliver practical training and problem-solving support across many jurisdictions, and the infrastructure to continuously track needs and adapt technical assistance as policy and program conditions evolve.

• The Department of Health and Human Services, Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.145.
• This funding opportunity was created on Aug 23, 2021.
• Applicants must submit their applications by Nov 22, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for HRSA 22 025

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: